Novel antifungal agents in clinical trials [version 2; peer review: 2 approved]

Invasive fungal diseases due to resistant yeasts and molds are an important and increasing public health threat, likely due to a growing population of immunosuppressed hosts, increases in antifungal resistance, and improvements in laboratory diagnostics. The significant morbidity and mortality asso...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	F1000 research Ročník 10; s. 507
Hlavní autori:	Jacobs, Samantha E, Zagaliotis, Panagiotis, Walsh, Thomas J
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England Faculty of 1000 Ltd 2022 F1000 Research Limited F1000 Research Ltd
Predmet:	Amphotericin B Antifungal Agents Antifungal Agents - pharmacology Antifungal Agents - therapeutic use Biosynthesis Clinical trials Drug dosages Drug interactions Drug Resistance, Fungal eng Enzymes Fungi Immunocompromised Host Meningitis Morbidity Neutropenia novel treatments Pathogens Pharmacodynamics pharmacokinetic and pharmacodynamic Pharmacokinetics Proteins Public health Review Antifungal Agents clinical trials pharmacokinetic and pharmacodynamic novel treatments
ISSN:	2046-1402, 2046-1402
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!